Literature DB >> 29600941

Adalimumab biosimilar in rheumatoid arthritis: a total-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.

Daniele Mengato1, Andrea Messori2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29600941

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  1 in total

1.  Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis.

Authors:  Cosimo Bruni; Stefano Gentileschi; Giovanni Pacini; Marco Bardelli; Lorenzo Tofani; Francesca Bartoli; Caterina Baldi; Laura Cometi; Ginevra Fiori; Francesca Nacci; Luca Cantarini; Serena Guiducci; Alberto Moggi-Pignone; Bruno Frediani; Marco Matucci-Cerinic
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-23       Impact factor: 5.346
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.